Sponsor or institution

Clinical trials and research at Shanghai Pulmonary Hospital, Shanghai, China

• 39Clinical trials
• 1New in 30 days
• 1Country

Newest trials

All recruiting trials (39)

• Becotatug Vedotin in relapsed SCLC: a single-center examine-what-works

  This study tests whether becotatug vedotin helps people whose small cell lung cancer has come back after prior treatment.

  Recruiting Shanghai Pulmonary Hospital, Shanghai, China · Shanghai · NCT07874581

• Neoadjuvant PD-L1/VEGF Bispecific Antibody with Chemo versus Chemo plus PD-1 Monoclonal Antibody in Locally Advanced NSCLC

  In people with locally advanced NSCLC, this study tests whether adding a PD-L1/VEGF bispecific antibody to chemotherapy before surgery improves outcomes compared with a PD-1 antibody added to chemotherapy.

  Recruiting at 2 sites Phase 3 Shanghai Pulmonary Hospital, Shanghai, China · Shanghai, China and 4 other locations · NCT07863999

• Biologics for Type 2 Inflammation in Asthma and COPD in Real World

  This real-world study tests whether six biologic drugs can reduce flare-ups and improve symptoms in adults with asthma or COPD treated in routine care in China.

  Recruiting Shanghai Pulmonary Hospital, Shanghai, China · Shanghai, Shanghai Municipality · NCT07823842

• Inspiratory Flow Rate Capability in Pulmonary Fibrosis Patients

  This observational study tests how fast patients with IPF or PPF can inhale through dry powder inhalers with different resistances.

  Recruiting Shanghai Pulmonary Hospital, Shanghai, China · Shanghai, Shanghai Municipality · NCT07820254

• Oral Paclitaxel with Immunotherapy and SBRT as Neoadjuvant Treatment for Older Adults with NSCLC

  This trial tests a new, lighter neoadjuvant therapy that combines an oral paclitaxel solution, an immune checkpoint inhibitor, and SBRT for adults aged 70 and older with resectable NSCLC to see if it can shrink tumors before surgery.

  Recruiting Phase 4 Shanghai Pulmonary Hospital, Shanghai, China · Guangzhou, Guangdong and 4 other locations · NCT07754812

• Targeted Induction Therapy for Stage III Unresectable EGFR Mutant NSCLC

  This trial tests a targeted induction approach using fumetinib with platinum-based chemotherapy and concurrent radiochemotherapy in adults with unresectable stage III EGFR-mutant NSCLC to see if this combo can improve outcomes before possible surgery.

  Recruiting Phase 2 Shanghai Pulmonary Hospital, Shanghai, China · Shanghai, Shanghai Municipality · NCT07742332

• Oliceridine vs Sufentanil for cough during anesthesia induction

  This trial tests whether oliceridine is better than sufentanil at reducing cough during anesthesia induction in adults undergoing elective surgery.

  Recruiting Phase 4 Shanghai Pulmonary Hospital, Shanghai, China · Tianmen, Hubei · NCT07660380

• Anti-CTLA-4 plus sintilimab and chemotherapy before surgery for resectable Stage II–III NSCLC

  This trial will test whether adding an anti-CTLA-4 antibody (IBI310) to sintilimab plus chemotherapy before surgery helps people with PD-L1–negative, resectable Stage II–III non-small cell lung cancer.

  Recruiting Phase 2 Shanghai Pulmonary Hospital, Shanghai, China · Shanghai, Shanghai Municipality · NCT07410975

• IBI363 plus chemotherapy before surgery for initially unresectable stage III non-small cell lung cancer

  This trial will try IBI363, an immunotherapy that targets PD‑1 and boosts IL‑2 signaling, together with platinum chemotherapy before surgery to see if it can shrink tumors enough for adults with initially unresectable stage III NSCLC.

  Recruiting Phase 2 Shanghai Pulmonary Hospital, Shanghai, China · Shanghai · NCT07408635

• Personalized treatment for non-small cell lung cancer using patient-derived tumor-like cell clusters

  This project will test whether tumor-like cell clusters from people with non-small cell lung cancer can help doctors pick immunotherapy, chemotherapy, or targeted drugs that work better for them.

  Recruiting Shanghai Pulmonary Hospital, Shanghai, China · Shanghai, Shanghai Municipality · NCT07328945

• Neoadjuvant sacituzumab tirumotecan plus limertinib for potentially resectable stage III EGFR‑mutant non‑small cell lung cancer

  This trial will test whether giving sacituzumab tirumotecan with limertinib before surgery can shrink stage III EGFR‑mutant non‑small cell lung cancers enough to allow safe resection.

  Recruiting Phase 2 Shanghai Pulmonary Hospital, Shanghai, China · Shanghai · NCT07323056

• Sugammadex versus neostigmine for early lung function recovery after thoracoscopic segmentectomy

  This trial will test whether giving sugammadex instead of neostigmine helps adults having small thoracoscopic lung resections recover breathing function faster after surgery.

  Recruiting at 3 sites Shanghai Pulmonary Hospital, Shanghai, China · Shanghai, Shanghai Municipality and 2 other locations · NCT07309393

• Multi-omics prediction of graft problems after lung transplant

  We will test whether repeated blood and lung-fluid multi-omics tests can spot early graft dysfunction in adults after lung transplantation.

  Recruiting Shanghai Pulmonary Hospital, Shanghai, China · Shanghai · NCT07243964

• Making PET-like images from CT to improve lung cancer diagnosis and care

  This project will test whether PET-like images generated from routine diagnostic CT scans can help doctors diagnose, stage, and plan treatment for people with non-small cell lung cancer who are having PET-CT and pathology tests.

  Recruiting at 5 sites Shanghai Pulmonary Hospital, Shanghai, China · Zunyi, Guizhou and 4 other locations · NCT07243873

• Long-acting versus standard intercostal nerve block after thoracoscopic lung surgery

  This will test whether a long-acting liposomal bupivacaine intercostal nerve block reduces postoperative pain more than standard bupivacaine or usual care in adults having thoracoscopic lung cancer surgery.

  Recruiting Shanghai Pulmonary Hospital, Shanghai, China · Shanghai · NCT07134660

• Sugemalimab with chemotherapy before surgery and continued after for resectable stage II–IIIA non-small cell lung cancer

  This study will test whether giving sugemalimab with chemotherapy before surgery and continuing sugemalimab after surgery helps adults with resectable stage II–IIIA non-small cell lung cancer who do not have EGFR or ALK mutations.

  Recruiting Phase 2 Shanghai Pulmonary Hospital, Shanghai, China · Shanghai, Shanghai Municipality · NCT06987734

• Research on bronchiectasis in Chinese patients using genomics and endotyping

  This study is trying to better understand different types of bronchiectasis in Chinese patients to find out how they respond to treatments and improve personalized care.

  Recruiting at 9 sites Shanghai Pulmonary Hospital, Shanghai, China · Guiyang, Guizhou and 8 other locations · NCT06900062

• Combining Atezolizumab with Chemotherapy for Small Cell Lung Cancer

  This study is testing whether adding atezolizumab to chemotherapy can help people with extensive-stage small cell lung cancer feel better and have fewer side effects compared to chemotherapy alone.

  Recruiting Shanghai Pulmonary Hospital, Shanghai, China · Shanghai · NCT06780826

• Long-term effects of inhaled Tobramycin on bronchiectasis patients

  This study is testing the long-term effects of a treatment that clears a specific lung infection in people with bronchiectasis to see how it improves their quality of life and lung health over time.

  Recruiting at 50 sites Shanghai Pulmonary Hospital, Shanghai, China · Hefei, Anhui and 57 other locations · NCT06760273

• Teniposide after prior therapy for c-Myc–driven extensive-stage small cell lung cancer

  This will try teniposide in people with extensive-stage small cell lung cancer driven by high c-Myc who have progressed after standard treatment.

  Recruiting Phase 2 Shanghai Pulmonary Hospital, Shanghai, China · Shanghai, Shanghai Municipality · NCT06758700

• Combining Befotertinib with Bevacizumab or Chemotherapy for Lung Cancer Treatment

  This study is testing if a new lung cancer treatment combining befotertinib with either bevacizumab or chemotherapy can help patients with early-stage cancer that has an EGFR mutation feel better before surgery.

  Recruiting Phase 2 Shanghai Pulmonary Hospital, Shanghai, China · Shanghai, Shanghai Municipality · NCT06755684

• Exploring a new treatment for advanced lung cancer using tislelizumab and chemotherapy

  This study is testing a new combination of treatments for people with advanced lung cancer who have already tried immunotherapy to see if it helps them live longer and feel better.

  Recruiting Phase 2 Shanghai Pulmonary Hospital, Shanghai, China · Shanghai · NCT06749886

• Combination treatment for advanced lung cancer with HER2 mutations

  This study is testing a new combination of treatments for people with advanced lung cancer that has HER2 mutations to see if it helps them live longer and feel better.

  Recruiting Phase 2 Shanghai Pulmonary Hospital, Shanghai, China · Shanghai · NCT06749860

• Using Benmelstobart for treating advanced lung adenocarcinoma after surgery

  This study is testing if the drug Benmelstobart can help people with advanced lung cancer stay cancer-free after surgery.

  Recruiting Phase 2 Shanghai Pulmonary Hospital, Shanghai, China · Shanghai, Shanghai Municipality · NCT06528847

• Combination therapy for limited-stage small cell lung cancer

  This study is testing a new combination of immunotherapy and chemotherapy to see if it can help people with limited-stage small cell lung cancer have better treatment results.

  Recruiting Phase 2 Shanghai Pulmonary Hospital, Shanghai, China · Shanghai · NCT06256237

• Exploring neoadjuvant therapy for lung cancer

  This study is testing how well different treatments before surgery, like chemotherapy and immunotherapy, can help people with lung cancer and what factors might affect their success.

  Recruiting Shanghai Pulmonary Hospital, Shanghai, China · Shanghai, Shanghai Municipality · NCT06216782

• Comparing robot-assisted and video-assisted surgery for thymoma treatment

  This study is testing whether robot-assisted surgery or video-assisted surgery is better for treating patients with thymoma.

  Recruiting Shanghai Pulmonary Hospital, Shanghai, China · Shanghai, Shanghai Municipality and 1 other locations · NCT06029621

• Neoadjuvant treatment for advanced thymic cancer

  This study is testing a new treatment that combines a medication with radiation therapy to see if it can help people with advanced thymic cancer have better surgery outcomes.

  Recruiting Phase 2 Shanghai Pulmonary Hospital, Shanghai, China · Shanghai, Shanghai Municipality · NCT06019468

• Monitoring molecular residual disease in lung cancer patients after surgery

  This study is testing a new way to check for leftover cancer cells in the blood and tissue of lung cancer patients after surgery to see if it can help predict and manage their chances of recurrence.

  Recruiting Shanghai Pulmonary Hospital, Shanghai, China · Shanghai, Shanghai Municipality · NCT05965024

• Investigating the effects of neoadjuvant therapy on lung cancer

  This study is testing how neoadjuvant therapy affects lung cancer patients by looking at changes in their tumors before surgery to see if it can help improve their treatment outcomes.

  Recruiting Shanghai Pulmonary Hospital, Shanghai, China · Shanghai · NCT05857800

• Comparing two surgical methods for small lung tumors

  This study is testing whether two different types of lung surgery work better for people with small lung tumors to see which one helps them live longer without the cancer coming back.

  Recruiting Shanghai Pulmonary Hospital, Shanghai, China · Yangpu, Shanghai Municipality · NCT05838053

• Combining immunotherapy and chemotherapy for advanced lung cancer treatment

  This study is testing a new treatment that combines immunotherapy with chemotherapy to see if it can help people with advanced lung cancer turn their tumors into ones that can be surgically removed.

  Recruiting Phase 2 Shanghai Pulmonary Hospital, Shanghai, China · Shanghai · NCT05766800

• Treatment for advanced lung cancer using furmonertinib and bevacizumab

  This study is testing a new combination of medications to see if it can help shrink tumors in patients with advanced lung cancer before surgery, making it easier to remove the cancer completely.

  Recruiting Phase 2 Shanghai Pulmonary Hospital, Shanghai, China · Shanghai, Shanghai Municipality · NCT05503667

• Immunotherapy for multidrug-resistant tuberculosis

  This study is testing a new immune therapy combined with standard TB treatment to see if it can help people with multidrug-resistant tuberculosis who haven't responded well to current medications.

  Recruiting at 2 sites Phase 4 Shanghai Pulmonary Hospital, Shanghai, China · Shanghai and 1 other locations · NCT05493267

• Microwave ablation combined with immune therapy for multiple lung cancers

  This study is testing whether combining microwave treatment with an immune therapy can help people with multiple lung cancers live longer and feel better.

  Recruiting at 6 sites Phase 2 Shanghai Pulmonary Hospital, Shanghai, China · Shanghai, Shanghai Municipality and 5 other locations · NCT05053802

• Comparing segmentectomy and lobectomy for small lung adenocarcinomas

  This study tests if a smaller surgery called segmentectomy is just as good as a larger surgery called lobectomy for people with small lung tumors to see which one helps them live longer and stay cancer-free.

  Recruiting at 14 sites Shanghai Pulmonary Hospital, Shanghai, China · Hefei, Anhui and 13 other locations · NCT04937283

• Neoadjuvant immunotherapy for stage III non-small cell lung cancer

  This study is testing a new treatment using a drug called Sintilimab, with or without chemotherapy, to see if it can shrink tumors in patients with stage III non-small cell lung cancer before they have surgery.

  Recruiting Phase 2 Shanghai Pulmonary Hospital, Shanghai, China · Shanghai · NCT04728724

• Combination of PD-L1 antibody and chemotherapy for small-cell lung cancer

  This study is testing a new combination of a PD-L1 antibody and chemotherapy to see if it helps people with limited-stage small-cell lung cancer feel better as their first treatment.

  Recruiting Phase 2 Shanghai Pulmonary Hospital, Shanghai, China · Shanghai, Shanghai Municipality · NCT04539977

• Comparing surgery alone versus surgery with chemotherapy for early-stage lung cancer

  This study is testing whether adding chemotherapy after surgery can help people with early-stage lung cancer live longer and stay cancer-free compared to just having surgery alone.

  Recruiting Phase 2 Shanghai Pulmonary Hospital, Shanghai, China · Shanghai · NCT03351842

Quick answers

How many clinical trials run by Shanghai Pulmonary Hospital, Shanghai, China are recruiting right now?

39, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 18, Phase 4: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →